SEHK:1358

Stock Analysis Report

Executive Summary

PW Medtech Group Limited, an investment holding company, operates as a medical device company in the People’s Republic of China.

Snowflake

Fundamentals

Mediocre balance sheet and slightly overvalued.

Share Price & News

How has PW Medtech Group's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-6.5%

1358

1.5%

HK Medical Equipment

2.9%

HK Market


1 Year Return

-21.8%

1358

8.3%

HK Medical Equipment

0.7%

HK Market

Return vs Industry: 1358 underperformed the Hong Kong Medical Equipment industry which returned 8.3% over the past year.

Return vs Market: 1358 underperformed the Hong Kong Market which returned 0.7% over the past year.


Shareholder returns

1358IndustryMarket
7 Day-6.5%1.5%2.9%
30 Day13.9%-0.9%-2.5%
90 Day18.6%19.0%-5.4%
1 Year-21.8%-21.8%9.5%8.3%4.4%0.7%
3 Year-53.6%-53.6%12.1%8.6%17.0%5.2%
5 Year-76.0%-76.0%2.1%-2.9%20.2%0.2%

Price Volatility Vs. Market

How volatile is PW Medtech Group's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is PW Medtech Group undervalued compared to its fair value and its price relative to the market?

11.92x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Undervalued: Insufficient data to calculate 1358's fair value to establish if it is undervalued.

Significantly Undervalued: Insufficient data to calculate 1358's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: 1358 is good value based on its PE Ratio (11.9x) compared to the Medical Equipment industry average (15.7x).

PE vs Market: 1358 is poor value based on its PE Ratio (11.9x) compared to the Hong Kong market (10.4x).


Price to Earnings Growth Ratio

Low PEG Ratio: Insufficient data to calculate 1358's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 1358 is good value based on its PB Ratio (0.4x) compared to the HK Medical Equipment industry average (1.6x).


Next Steps

Future Growth

How is PW Medtech Group forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

15.3%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as PW Medtech Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has PW Medtech Group performed over the past 5 years?

-22.2%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: 1358's earnings have declined by -22.2% per year over the past 5 years.

Accelerating Growth: 1358's earnings growth over the past year (404.5%) exceeds its 5-year average (-22.2% per year).

Earnings vs Industry: 1358 earnings growth over the past year (404.5%) exceeded the Medical Equipment industry 50.2%.


Return on Equity

High ROE: 1358's Return on Equity (3%) is considered low.


Return on Assets

ROA vs Industry: 1358's Return on Assets is below or equal to the Medical Equipment industry average last year.


Return on Capital Employed

ROCE Improving: 1358's Return on Capital Employed has declined over the past 3 years.


Next Steps

Financial Health

How is PW Medtech Group's financial position?


Financial Position Analysis

Short Term Liabilities: 1358's short term assets (CN¥392.8M) do not cover its short term liabilities (CN¥691.2M)

Long Term Liabilities: 1358's short term assets (392.8M) exceeds its long term liabilities (8.2M)


Debt to Equity History and Analysis

Debt Level: 1358's debt to equity ratio (12.7%) is considered satisfactory

Reducing Debt: 1358's debt to equity ratio has reduced from 13.8% to 12.7% over the past 5 years.

Debt Coverage: 1358's debt is not well covered by operating cash flow (14.4%).

Interest Coverage: 1358's interest payments on its debt are not well covered by EBIT (2x coverage).


Balance Sheet

Inventory Level: 1358 has a low level of unsold assets or inventory.

Debt Coverage by Assets: 1358's debt is not covered by short term assets (assets are 0.7x debt).


Next Steps

Dividend

What is PW Medtech Group's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%2.2%markettop25%6.3%industryaverage1.2%forecastin3Years0%

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate 1358's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate 1358's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if 1358's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 1358's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of 1358's dividend in 3 years as they are not forecast to pay a notable one for the Hong Kong market.


Next Steps

Management

What is the CEO of PW Medtech Group's salary, the management and board of directors tenure and is there insider trading?

6.0yrs

Average board tenure


CEO

Yue'e Zhang (56yo)

0.6yrs

Tenure

CN¥995,000

Compensation

Ms. Yue'e Zhang has been Chief Executive Officer at PW Medtech Group Ltd. since March 31, 2019. Ms. Zhang serves as a General Manager, Senior Engineer and Executive Director of WP Medical Technologies, Inc ...


CEO Compensation Analysis

Compensation vs. Market: Yue'e has recently become CEO, making it difficult to compare their total compensation against companies of similar size in the Hong Kong market.

Compensation vs Earnings: Yue'e's compensation has been consistent with company performance over the past year.


Board Age and Tenure

6.0yrs

Average Tenure

54yo

Average Age

Experienced Board: 1358's board of directors are considered experienced (6 years average tenure).


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

BuyCN¥33,880,09024 Jan 19
Yufeng Liu
EntityIndividual
Shares28,000,000
Max PriceCN¥1.21

Ownership Breakdown


Management Team

  • Yue'e Zhang (56yo)

    Chairman & CEO

    • Tenure: 0.6yrs
    • Compensation: CN¥995.00k
  • Lingyan Ding (31yo)

    Financial Director

    • Tenure: 0yrs
  • Tin Yu Wong

    Company Secretary

    • Tenure: 0.3yrs

Board Members

  • Xiaogang Wang (46yo)

    Independent Non-Executive Director

    • Tenure: 6yrs
    • Compensation: CN¥169.00k
  • Geng Chen (48yo)

    Independent Non-Executive Director

    • Tenure: 6yrs
    • Compensation: CN¥169.00k
  • Xingdong Zhang (81yo)

    Independent Non-Executive Director

    • Tenure: 6yrs
    • Compensation: CN¥169.00k
  • Liwei Jiang (52yo)

    Non-Executive Director

    • Tenure: 6.3yrs
    • Compensation: CN¥1.61m
  • Junshan Lin (57yo)

    Non-Executive Director

    • Tenure: 6.3yrs
    • Compensation: CN¥300.00k
  • Yue'e Zhang (56yo)

    Chairman & CEO

    • Tenure: 0.6yrs
    • Compensation: CN¥995.00k

Company Information

PW Medtech Group Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: PW Medtech Group Limited
  • Ticker: 1358
  • Exchange: SEHK
  • Founded: 2011
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: HK$1.820b
  • Shares outstanding: 1.57b
  • Website: https://www.pwmedtech.com

Number of Employees


Location

  • PW Medtech Group Limited
  • Building 1, Courtyard 23
  • Panlong West Road
  • Beijing
  • China

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
1358SEHK (The Stock Exchange of Hong Kong Ltd.)YesOrdinary SharesHKHKDNov 2013
PWEDB (Deutsche Boerse AG)YesOrdinary SharesDEEURNov 2013

Biography

PW Medtech Group Limited, an investment holding company, operates as a medical device company in the People’s Republic of China. It manufactures and sells infusion sets, such as non-PVC-based infusion sets ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/15 12:49
End of Day Share Price2019/10/15 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.